Fatma H. Awadhi-Al

Safat, KU 13110, Kuwait

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Isolation and Characterization of the Cyanobacterial Macrolide Glycoside Moorenaside, an Anti-Inflammatory Analogue of Aurisides Targeting the Keap1/Nrf2 Pathway.

Isolation and Characterization of the Cyanobacterial Macrolide Glycoside Moorenaside, an Anti-Inflammatory Analogue of Aurisides Targeting the Keap1/Nrf2 Pathway.

Journal: Journal of natural products

Published: September 24, 2024

Empowering competence: A program-wide active learning framework for a pharmacy program.

Empowering competence: A program-wide active learning framework for a pharmacy program.

Journal: American journal of pharmaceutical education

Published: May 01, 2024

Discovery and Anti-Inflammatory Activity of a Cyanobacterial Fatty Acid Targeting the Keap1/Nrf2 Pathway.

Discovery and Anti-Inflammatory Activity of a Cyanobacterial Fatty Acid Targeting the Keap1/Nrf2 Pathway.

Journal: Marine drugs

Published: September 14, 2023

Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases.

Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases.

Journal: ACS chemical neuroscience

Published: June 20, 2020

Targeting eukaryotic proteases for natural products-based drug development.

Targeting eukaryotic proteases for natural products-based drug development.

Journal: Natural product reports

Published: June 11, 2020

Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium.

Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium.

Journal: Journal of medicinal chemistry

Published: July 18, 2018

Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer.

Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer.

Journal: Chembiochem : a European journal of chemical biology

Published: November 27, 2017

Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.

Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.

Journal: Journal of natural products

Published: November 01, 2017

Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer.

Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer.

Journal: Marine drugs

Published: April 01, 2017

Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium.

Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium.

Journal: Bioorganic & medicinal chemistry

Published: February 22, 2016

Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties.

Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties.

Journal: ACS medicinal chemistry letters

Published: April 29, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026